Popular hypertension drugs don’t increase risk of COVID-19 severity, fatality

A new Northwestern Medicine study in mice found a widely used class of drugs to treat patients with hypertension, cardiovascular disease and diabetic kidney disease—many of whom are elderly—does not increase the risk of developing a severe and potentially fatal COVID-19 infection, as previously feared.